GoldenGolden
Advanced Search
Pontifax Venture Capital

Pontifax Venture Capital

Israeli venture capital firm funding Israeli bio-pharmaceutical and life science companies.

All edits

Edits on 20 Apr, 2021
Golden AI
Golden AI edited on 20 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
StrideBio
Edits on 29 Mar, 2021
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Oct, 2019
Jed Christiansen
Jed Christiansen edited on 7 Oct, 2019
Edits made to:
Infobox (+3/--1 properties)
Infobox
Edits on 15 Aug, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 15 Aug, 2019
Edits made to:
Infobox (+1 properties)
Article
Article

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Infobox
Edits on 11 Apr, 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 11 Apr, 2019
Edits made to:
Article (+20/-20 characters)
Article

Pontifax Venture Capital is a venture capital firmventure capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 11 Apr, 2019
Edits made to:
Article (+8/-8 characters)
Article

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in HerzliyaHerzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 11 Apr, 2019
Edits made to:
Article (+6/-6 characters)
Article

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, IsraelIsrael. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.